Literature DB >> 24016099

Apratoxin H and apratoxin A sulfoxide from the Red Sea cyanobacterium Moorea producens.

Christopher C Thornburg1, Elise S Cowley, Justyna Sikorska, Lamiaa A Shaala, Jane E Ishmael, Diaa T A Youssef, Kerry L McPhail.   

Abstract

Cultivation of the marine cyanobacterium Moorea producens, collected from the Nabq Mangroves in the Gulf of Aqaba (Red Sea), led to the isolation of new apratoxin analogues apratoxin H (1) and apratoxin A sulfoxide (2), together with the known apratoxins A-C, lyngbyabellin B, and hectochlorin. The absolute configuration of these new potent cytotoxins was determined by chemical degradation, MS, NMR, and CD spectroscopy. Apratoxin H (1) contains pipecolic acid in place of the proline residue present in apratoxin A, expanding the known suite of naturally occurring analogues that display amino acid substitutions within the final module of the apratoxin biosynthetic pathway. The oxidation site of apratoxin A sulfoxide (2) was deduced from MS fragmentation patterns and IR data, and 2 could not be generated experimentally by oxidation of apratoxin A. The cytotoxicity of 1 and 2 to human NCI-H460 lung cancer cells (IC₅₀ = 3.4 and 89.9 nM, respectively) provides further insight into the structure-activity relationships in the apratoxin series. Phylogenetic analysis of the apratoxin-producing cyanobacterial strains belonging to the genus Moorea, coupled with the recently annotated apratoxin biosynthetic pathway, supports the notion that apratoxin production and structural diversity may be specific to their geographical niche.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24016099      PMCID: PMC3969888          DOI: 10.1021/np4004992

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  38 in total

1.  jModelTest: phylogenetic model averaging.

Authors:  David Posada
Journal:  Mol Biol Evol       Date:  2008-04-08       Impact factor: 16.240

2.  Dendroamides, new cyclic hexapeptides from a blue-green alga. Multidrug-resistance reversing activity of dendroamide A.

Authors:  J Ogino; R E Moore; G M Patterson; C D Smith
Journal:  J Nat Prod       Date:  1996-06       Impact factor: 4.050

3.  A nomenclature system for labeling cyclic peptide fragments.

Authors:  L C Ngoka; M L Gross
Journal:  J Am Soc Mass Spectrom       Date:  1999-04       Impact factor: 3.109

4.  Haligramides A and B, two new cytotoxic hexapeptides from the marine sponge Haliclona nigra.

Authors:  M A Rashid; K R Gustafson; J L Boswell; M R Boyd
Journal:  J Nat Prod       Date:  2000-07       Impact factor: 4.050

5.  Anti-inflammatory thiazine alkaloids isolated from the New Zealand ascidian Aplidium sp.: inhibitors of the neutrophil respiratory burst in a model of gouty arthritis.

Authors:  A Norrie Pearce; Elizabeth W Chia; Michael V Berridge; George R Clark; Jacquie L Harper; Lesley Larsen; Elizabeth W Maas; Michael J Page; Nigel B Perry; Victoria L Webb; Brent R Copp
Journal:  J Nat Prod       Date:  2007-05-11       Impact factor: 4.050

6.  Carriebowmide, a new cyclodepsipeptide from the marine cyanobacterium Lyngbya polychroa.

Authors:  Sarath P Gunasekera; Raphael Ritson-Williams; Valerie J Paul
Journal:  J Nat Prod       Date:  2008-12       Impact factor: 4.050

7.  New screening software shows that most recent large 16S rRNA gene clone libraries contain chimeras.

Authors:  Kevin E Ashelford; Nadia A Chuzhanova; John C Fry; Antonia J Jones; Andrew J Weightman
Journal:  Appl Environ Microbiol       Date:  2006-09       Impact factor: 4.792

8.  At least 1 in 20 16S rRNA sequence records currently held in public repositories is estimated to contain substantial anomalies.

Authors:  Kevin E Ashelford; Nadia A Chuzhanova; John C Fry; Antonia J Jones; Andrew J Weightman
Journal:  Appl Environ Microbiol       Date:  2005-12       Impact factor: 4.792

9.  Single cell genome amplification accelerates identification of the apratoxin biosynthetic pathway from a complex microbial assemblage.

Authors:  Rashel V Grindberg; Thomas Ishoey; Dumitru Brinza; Eduardo Esquenazi; R Cameron Coates; Wei-ting Liu; Lena Gerwick; Pieter C Dorrestein; Pavel Pevzner; Roger Lasken; William H Gerwick
Journal:  PLoS One       Date:  2011-04-12       Impact factor: 3.240

10.  Systematic Chemical Mutagenesis Identifies a Potent Novel Apratoxin A/E Hybrid with Improved in Vivo Antitumor Activity.

Authors:  Qi-Yin Chen; Yanxia Liu; Hendrik Luesch
Journal:  ACS Med Chem Lett       Date:  2011-08-31       Impact factor: 4.345

View more
  25 in total

1.  Jizanpeptins, Cyanobacterial Protease Inhibitors from a Symploca sp. Cyanobacterium Collected in the Red Sea.

Authors:  David A Gallegos; Josep Saurí; Ryan D Cohen; Xuemei Wan; Patrick Videau; Alec O Vallota-Eastman; Lamiaa A Shaala; Diaa T A Youssef; R Thomas Williamson; Gary E Martin; Benjamin Philmus; Aleksandra E Sikora; Jane E Ishmael; Kerry L McPhail
Journal:  J Nat Prod       Date:  2018-05-29       Impact factor: 4.050

2.  Total Synthesis and Biological Evaluation of Apratoxin E and Its C30 Epimer: Configurational Reassignment of the Natural Product.

Authors:  Ping Wu; Weijing Cai; Qi-Yin Chen; Senhan Xu; Ruwen Yin; Yingxia Li; Wei Zhang; Hendrik Luesch
Journal:  Org Lett       Date:  2016-10-10       Impact factor: 6.005

3.  Pseudanabaena galeata CCNP1313-Biological Activity and Peptides Production.

Authors:  Marta Cegłowska; Karolina Szubert; Beata Grygier; Marzena Lenart; Jacek Plewka; Aleksandra Milewska; Kinga Lis; Artur Szczepański; Yuliya Chykunova; Emilia Barreto-Duran; Krzysztof Pyrć; Alicja Kosakowska; Hanna Mazur-Marzec
Journal:  Toxins (Basel)       Date:  2022-05-06       Impact factor: 5.075

4.  Canine osteosarcoma cells exhibit basal accumulation of multiple chaperone proteins and are sensitive to small molecule inhibitors of GRP78 and heat shock protein function.

Authors:  Daphne R Mattos; Marcus A Weinman; Xuemei Wan; Cheri P Goodall; Jeffrey D Serrill; Kerry L McPhail; Milan Milovancev; Shay Bracha; Jane E Ishmael
Journal:  Cell Stress Chaperones       Date:  2022-03-04       Impact factor: 3.827

5.  Development of apratoxin S10 (Apra S10) as an anti-pancreatic cancer agent and its preliminary evaluation in an orthotopic patient-derived xenograft (PDX) model.

Authors:  Weijing Cai; Ranjala Ratnayake; Michael H Gerber; Qi-Yin Chen; Yichao Yu; Hartmut Derendorf; Jose G Trevino; Hendrik Luesch
Journal:  Invest New Drugs       Date:  2018-08-03       Impact factor: 3.850

6.  Coibamide A, a natural lariat depsipeptide, inhibits VEGFA/VEGFR2 expression and suppresses tumor growth in glioblastoma xenografts.

Authors:  Jeffrey D Serrill; Xuemei Wan; Andrew M Hau; Hyo Sang Jang; Daniel J Coleman; Arup K Indra; Adam W G Alani; Kerry L McPhail; Jane E Ishmael
Journal:  Invest New Drugs       Date:  2015-11-12       Impact factor: 3.850

7.  Apratoxin S10, a Dual Inhibitor of Angiogenesis and Cancer Cell Growth To Treat Highly Vascularized Tumors.

Authors:  Weijing Cai; Qi-Yin Chen; Long H Dang; Hendrik Luesch
Journal:  ACS Med Chem Lett       Date:  2017-09-18       Impact factor: 4.345

8.  Forazoline A: marine-derived polyketide with antifungal in vivo efficacy.

Authors:  Thomas P Wyche; Jeff S Piotrowski; Yanpeng Hou; Doug Braun; Raamesh Deshpande; Sean McIlwain; Irene M Ong; Chad L Myers; Ilia A Guzei; William M Westler; David R Andes; Tim S Bugni
Journal:  Angew Chem Int Ed Engl       Date:  2014-09-04       Impact factor: 15.336

9.  Targeting of HER/ErbB family proteins using broad spectrum Sec61 inhibitors coibamide A and apratoxin A.

Authors:  Soheila Kazemi; Shinsaku Kawaguchi; Christian E Badr; Daphne R Mattos; Ana Ruiz-Saenz; Jeffrey D Serrill; Mark M Moasser; Brian P Dolan; Ville O Paavilainen; Shinya Oishi; Kerry L McPhail; Jane E Ishmael
Journal:  Biochem Pharmacol       Date:  2020-11-03       Impact factor: 5.858

10.  Genome Reduction and Secondary Metabolism of the Marine Sponge-Associated Cyanobacterium Leptothoe.

Authors:  Despoina Konstantinou; Rafael V Popin; David P Fewer; Kaarina Sivonen; Spyros Gkelis
Journal:  Mar Drugs       Date:  2021-05-24       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.